Back to search

Article

Ultra-high dose oral <i>ω</i> 3 docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA) block tumorigenesis in a <i>MYCN</i> -driven neuroblastoma model

2024-06-03

Abstract excerpt

<h4>Background/Objectives</h4> Neuroblastoma is a genetically diverse, highly metastatic pediatric cancer accounting for 15% of childhood cancer deaths despite only having ~8% of childhood cancer incidence. The current standard of care for high-risk disease is highly genotoxic. This, combined with less than 50% survival in high-risk disease and an abysmal 5% survival in relapsed cases, makes discovering novel, ef...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a2171328-0402-58b7-8fff-4ab054febf2f
DOI
10.1101/2024.05.30.596731
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Ultra-high dose oral <i>ω</i> 3 docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA) block tumorigenesis in a <i>MYCN</i> -driven neuroblastoma modelDOI 10.1101/2024.05.30.596731
The Lipid Switch: Ultra-High Dose Omega Fatty Acids Determine MYCN Neuroblastoma Fate Through Oxylipin CompetitionSemantic proximity
Omega‐3 fatty acid supplementation delays the progression of neuroblastoma <i>in vivo</i>Semantic proximity
Inhibition of fatty acid synthesis induces differentiation and reduces tumor burden in childhood neuroblastomaSemantic proximity
Unsaturated fatty acid synthesis is associated with poor prognosis and differentially regulated by <i>MYCN</i> and tumor suppressor microRNAs in neuroblastomaSemantic proximity
Anti-GD2 antibody therapy alters the neuroblastoma tumor microenvironment and extends survival in <i>TH-MYCN</i> miceSemantic proximity
Disrupting Polyamine Homeostasis as a Therapeutic Strategy for NeuroblastomaSemantic proximity
Epigenetic reprogramming of melanoma cell state through fatty acid β-oxidation and Toll-like receptor 4 signalingSemantic proximity
Inhibition of Neuroblastoma Tumor Growth by Ketogenic Diet and/or Calorie Restriction in a CD1-Nu Mouse ModelSemantic proximity
Unsaturated Fatty Acid Synthesis Is Associated with Worse Survival and Is Differentially Regulated by MYCN and Tumor Suppressor microRNAs in NeuroblastomaSemantic proximity
ALK/ATR combination therapy is effective in neuroblastoma mouse tumors driven by MYCNSemantic proximity
The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome.Semantic proximity
Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastomaSemantic proximity
Select a neighboring publication to make it the new centre.